Managed Care Cast Presents: Opportunities for Adalimumab Bio

In part 2 of this 2-part podcast, a panel of experts discusses implementation biosimilars in biologic-naïve patients, auto-substitution, and more.

Related Keywords

Ryan Haumschild , Winship Cancer Institute , Pharmacy Services At Emory Healthcare , Pharmacy Services , Emory Healthcare , Winship Cancer , Biosimilars , Interchangeability , Adalimumab , Dermatology , Rheumatology , Gastroenterology ,